# Aralez

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aralez

- Industry: Biotechnology
- Headquarters: San Leandro, US
- Website: www.aralezbio.com/
- Total disclosed funding: $12M
- Latest round: Series A (Jun 4, 2024)
- Investors on record: 9

## About

Founded in 2019 and based in California, US, Aralez, Inc., aka Aralez Bio specializes in the development and manufacture of noncanonical amino acids. Tina Boville (CEO), David Romney (CTO), and Frances Arnold are the co-founders of the company. In October 2024, Aralez Bio raised USD 12 million in Series A funding led by Spero Ventures, including Paladin Capital Group, Good Growth Capital, Astia Angels, Heritage Medical Systems, Freeflow Ventures, Impact Science Ventures, Juniper Ventures, and Pineapple Venture Capital.

Aralez Bio specializes in the development and manufacture of noncanonical amino acids, which are essential components utilized in biotechnology and pharmaceuticals. The firm’s unique enzymatic technology enables the production of these amino acids. The company's offerings cater to a diverse clientele, including pharmaceutical companies, peptide manufacturers, and research organizations, addressing needs in peptide synthesis, small molecule design, and drug conjugates, thereby contributing to advancements in next-generation therapeutics. Aralez Bio serves a global market with customers across North America, Europe, and Asia.

Aralez Bio generates revenue primarily through B2B transactions with pharmaceutical companies and biotech firms. Their customer engagement involves partnerships and direct sales where clients access tailored solutions for amino acid production.

The organization plans to use the October 2024 funding to expand its noncanonical amino acid inventory and enhance manufacturing capabilities.

## Funding rounds

- Series A, Jun 4, 2024, $12M — Paladin Capital Group, Juniper Ventures, Astia Angels, Good Growth Capital, Pineapple Venture Capital, Spero Ventures, Freeflow Ventures, Heritage Medical Systems, Impact Science Ventures

## Investors

- Paladin Capital Group (https://capitalatlas.ai/funds/paladin-capital-group) — Series A
- Juniper Ventures — Series A
- Astia Angels (https://capitalatlas.ai/funds/astia-angels) — Series A
- Good Growth Capital (https://capitalatlas.ai/funds/good-growth-capital) — Series A
- Pineapple Venture Capital (https://capitalatlas.ai/funds/pineapple-venture-capital) — Series A
- Spero Ventures (https://capitalatlas.ai/funds/spero-ventures) — Series A
- Freeflow Ventures (https://capitalatlas.ai/funds/freeflow-ventures) — Series A
- Heritage Medical Systems — Series A
- Impact Science Ventures (https://capitalatlas.ai/funds/impact-science-ventures) — Series A